IN SILICO STUDY OF THE CONSTITUENTS OF AROEIRA HONEY (Astronium urundeuva) AND THE CAPACITY OF INTERACTION WITH LEISHMANIOSIS PROTEINASE GP63
Neglected tropical diseases represent a significant source of morbidity and mortality in developing countries, representing a global health challenge. Honey produced by bees is an organic food, composed of a mixture rich in nutrients, such as carbohydrates, amino acids, fatty acids, enzymes, mineral...
| Autores: | , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2024 |
| País: | Brasil |
| Institución: | Instituto Federal de Educação, Ciência e Tecnologia do Espírito Santo (IFES) |
| Repositorio: | Revista Eletrônica Debates em Educação Científica e Tecnológica |
| Idioma: | portugués |
| OAI Identifier: | oai::article/2849 |
| Acceso en línea: | https://ojs.ifes.edu.br/index.php/ric/article/view/2849 |
| Access Level: | acceso abierto |
| Palabra clave: | Astronium urundeuva mastic honey leishmaniasis GP63 in silico mel da aroeira leishmaniose |
| Sumario: | Neglected tropical diseases represent a significant source of morbidity and mortality in developing countries, representing a global health challenge. Honey produced by bees is an organic food, composed of a mixture rich in nutrients, such as carbohydrates, amino acids, fatty acids, enzymes, minerals and vitamins. Depending on flowering, honey may contain phenolic compounds, flavorings and flavonoids, which may exhibit biological activities. In this in silico study on the constituents of mastic honey (Astronium urundeuva), we sought to predict the physicochemical, pharmacokinetic and toxicological properties, considering the interaction capacity of the constituents with the GP63 receptor, from Leishmaniasis. To this end, a systematic review of the literature was carried out and the molecular structures of the constituents were obtained, predicting ADMET properties and evaluating the binding affinity with molecular docking. Thus, information was obtained on the in silico physicochemical and pharmacological properties of the identified compounds, highlighting the potential biological activity for the treatment of Leishmaniasis, through the ability to interact with the GP63 protease. This focus will enable new investigations and therapeutic advances in the area. |
|---|